Mesalamine
Mesalamine, sold as Rowasa and sfRowasa (sulfite-free), is a rectal enema medication used to treat inflammation in the colon, such as in ulcerative colitis. It works by reducing swelling and irritation in the intestines. Administer as directed by a doctor, typically once daily at bedtime. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Mesalamine, sold as Rowasa and sfRowasa (sulfite-free), is a rectal enema medication used to treat inflammation in the colon, such as in ulcerative colitis. It works by reducing swelling and irritation in the intestines. Administer as directed by a doctor, typically once daily at bedtime. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Mesalamine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Mesalamine — ANDA 216941 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216941"
}
]
|
| identifier | ANDA216941 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Mesalamine |
